Eversense is the only long-term CGM system with 6 months of real-time glucose readings and only 2 sensors per year. Because you have life to manage, not just diabetes.
Benefits of switching to Eversense
Eversense E3 is the only CGM that offers more flexibility with a single implanted sensor. You get 6 months of continuous real-time glucose readings which means only two sensor replacements and warm up periods per year.
Only Eversense has a removable transmitter that can be taken on and off without wasting a sensor. And unlike other short-term CGMs, with Eversense you’ll get on-body vibe alerts that can discreetly notify when you’re experiencing highs or lows.
Eversense gives you real-time glucose readings through a small sensor that’s placed just under the skin of your upper arm by a healthcare professional. The smart transmitter sits above the sensor, sending glucose data to your app.
The sensor is inserted in the upper arm by an Eversense Inserter in a simple in-office procedure and continuously measures glucose for 6 months. That's only two sensors per year - say goodbye to self-insertions every 10-14 days!
Worn over the sensor, the rechargeable transmitter wirelessly sends data to your mobile device; the easy-on, easy-off smart transmitter* and gentle, daily use adhesive allow you to take a break without wasting a sensor.
The intuitive app provides you with real-time glucose readings that are updated every 5 minutes, these readings provide predictive alerts for highs and lows. The data collected can then be shared with up to 5 people, so your friends and family members can stay informed remotely through the Eversense NOW app.
To be eligible for Eversense you must be an adult with diabetes and be using insulin. You’ll also need to see if you qualify with your insurance provider.
Once approved by insurance, an Eversense representative will connect you with an Inserter near you to schedule your insertion procedure.
300+ million people have insurance that covers the Eversense E3 CGM System.
Through the Payment Assistance and Simple Savings (PASS) program, you may be eligible for a $99 offer** for your sensor and transmitter and subsequent sensors.*
You can also pay with pre-tax dollars from your FSA or HSA.
Learn more about the process, from qualifying for Eversense to setting up your system.
Start by filling out our brief “Get Started” form
Once an Eversense representative confirms your eligibility, they’ll work with you to find an Eversense Inserter in your area.
An Eversense representative will then communicate directly with your insurance provider and physician.
Once approved, we’ll have your Eversense delivered to your Inserter.
We’ll notify you once your Eversense has shipped, so you can schedule your upcoming insertion appointment.
The procedure will take several minutes and your Eversense Inserter can answer any questions you have about the insertion process.
During your visit they’ll ensure your app is set up, and that the transmitter is paired to the sensor.
Then begins your 6 months of continuous glucose monitoring with more convenience, comfort and flexibility!
A Diabetes Therapy Associate will be in touch shortly, but if you want to reach out sooner, please call 1-945-221-9068.
To help expedite benefits verification, please have your doctor and insurance information handy.
We will attempt to reach you by phone first, and will send a text and email as well. The call may be displayed on your phone as "Eversense CGM". However, it will come from a number you are unfamiliar with, so be sure to check your voicemail box. The email from our representative will come from an @ascensia.com email address. If you haven’t received any email communications from our team within a few days, please check the spam folder in your email account.
You can also schedule your call with us at a date/time that is most convenient for you - just click here.
Looking forward to getting in touch with you!
Unfortunately, based on the insulin therapy regimen or insurance information you provided, you may not be eligible for Eversense E3 CGM. In order to qualify, you must be on multiple daily doses of insulin.
If your commercial insurance plan does not cover Eversense E3 CGM, our Eversense PASS™ program may help reduce your out-of-pocket cost for the product.
If you have any questions, please reach out to 1-844-736-7348.
If you're on insulin, you might greatly benefit from Eversense. After completing the form below, an Eversense representative will be in touch to discuss eligibility, coverage and next steps.
Please note: Eversense® E3 CGM is indicated for persons with diabetes age 18 and older.
A Diabetes Therapy Associate will be in touch shortly, but if you want to reach out sooner, please call 1-945-221-9068.
To help expedite benefits verification, please have your doctor and insurance information handy.
We will attempt to reach you by phone first, and will send a text and email as well. The call may be displayed on your phone as "Eversense CGM". However, it will come from a number you are unfamiliar with, so be sure to check your voicemail box. The email from our representative will come from an @ascensia.com email address. If you haven’t received any email communications from our team within a few days, please check the spam folder in your email account.
You can also schedule your call with us at a date/time that is most convenient for you - just click here.
Looking forward to getting in touch with you!
Unfortunately, based on the insulin therapy regimen or insurance information you provided, you may not be eligible for Eversense E3 CGM. In order to qualify, you must be on multiple daily doses of insulin.
If you do not have insurance, or if your insurance carrier does not cover Eversense E3 CGM, our PASS Program may help make Eversense E3 more accessible.
If you have any questions, please reach out to 1-844-736-7348.
If you're on insulin, you might greatly benefit from Eversense. After completing the form below, an Eversense representative will be in touch to discuss eligibility, coverage and next steps.
Please note: Eversense® E3 CGM is indicated for persons with diabetes age 18 and older.
